Acquired
Novo Nordisk (Ozempic)
David Rosenthal
Right. So, you know, what's going on here and why is Lada pushing for this? You know, she's a great scientist, well-respected, you know, and at this point she's made her career on the development of liraglutide and GLP-1 against all odds just for diabetes. Why is she pushing this? This is a very, very different situation than what happened with Fen-Phen.
0
💬
0
Comments
Log in to comment.
There are no comments yet.